Scientific article
Open access

Local Cisplatin Delivery in Mouse Reliably Models Sensorineural Ototoxicity Without Systemic Adverse Effects

Published inFrontiers in cellular neuroscience, vol. 15, 701783
Publication date2021
First online date2021-07-14

Cisplatin is a lifesaving chemotherapeutic drug with marked ototoxic adverse effects. Cisplatin-induced hearing loss affects a significant part of cancer-surviving patients and is an unmet clinical need with important socioeconomic consequences. Unfortunately, in current preclinical animal models of cisplatin ototoxicity, which are mainly based on systemic delivery, important morbidity is observed, leading to premature death. This methodology not only raises obvious animal welfare concerns but also increases the number of animals used in ototoxicity studies to compensate for dropouts related to early death. To overcome these important limitations, we developed a local delivery model based on the application of a cisplatin solution directly into the otic bulla through a retroauricular approach. The local delivery model reliably induced significant hearing loss with a mean threshold shift ranging from 10 to 30 dB, strongly affecting the high frequencies (22 and 32 kHz). Importantly, mice did not show visible stress or distress indicators and no significant morbidity in comparison with a traditional systemic delivery control group of mice injected intraperitoneally with 10 mg/kg cisplatin, where significant weight loss >10% in all treated animals (without any recovery) led to premature abortion of experiments on day 3. Mass spectrometry confirmed the absence of relevant systemic uptake after local delivery, with platinum accumulation restricted to the cochlea, whereas important platinum concentrations were detected in the liver and kidney of the systemic cisplatin group. A clear correlation between the cochlear platinum concentration and the auditory threshold shift was observed. Immunohistochemistry revealed statistically significant loss of outer hair cells in the basal and apical turns of the cochlea and an important and statistically significant loss of auditory neurons and synapses in all cochlear regions. In conclusion, local cisplatin delivery induces robust hearing loss with minimal morbidity, thereby offering a reliable rodent model for human cisplatin ototoxicity, reducing the number of animals required and showing improved animal welfare compared with traditional systemic models.

  • Animal welfare
  • Cisplatin ototoxicity
  • Cochlea
  • Mass spectrometry
  • Middle ear delivery
  • Refinement
Citation (ISO format)
NACHER SOLER, German et al. Local Cisplatin Delivery in Mouse Reliably Models Sensorineural Ototoxicity Without Systemic Adverse Effects. In: Frontiers in cellular neuroscience, 2021, vol. 15, p. 701783. doi: 10.3389/fncel.2021.701783
Main files (1)
Article (Published version)
Secondary files (1)
ISSN of the journal1662-5102

Technical informations

Creation02/10/2022 2:20:00 PM
First validation02/10/2022 2:20:00 PM
Update time03/16/2023 2:40:39 AM
Status update03/16/2023 2:40:37 AM
Last indexation08/31/2023 7:44:20 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack